TABLE 2.
Demographics and biological data of study participants at screening1
| All participants (n = 30) | Men (n = 14) | Women (n = 16) | |
|---|---|---|---|
| Age, y | 33.6 ± 6.79 | 36.7 ± 5.50 | 30.8 ± 6.75 |
| Height, cm | 170 ± 10.3 | 179 ± 5.15 | 163 ± 8.16 |
| Weight, kg | 64.5 ± 11.1 | 72.8 ± 8.33 | 57.3 ± 7.61 |
| BMI, kg/m² | 22.1 ± 2.13 | 22.8 ± 2.45 | 21.4 ± 1.61 |
| Systolic blood pressure, mmHg | 124 ± 15 | 127 ± 15 | 121 ± 14 |
| Diastolic blood pressure, mmHg | 75 ± 9 | 78 ± 10 | 72 ± 7 |
| Heart rate, bpm | 66 ± 11 | 63 ± 11 | 69 ± 11 |
| Glucose, g/L | 0.91 ± 0.079 | 0.96 ± 0.070 | 0.87 ± 0.063 |
| Creatinine, μmol/L | 67.0 ± 11 | 75.1 ± 9.62 | 60.0 ± 6.24 |
| Urea, mmol/L | 4.02 ± 1.04 | 4.19 ± 0.974 | 3.86 ± 1.10 |
| SGPT, μkat/L | 0.34 ± 0.244 | 0.47 ± 0.236 | 0.23 ± 0.193 |
| SGOT, μkat/L | 0.35 ± 0.119 | 0.40 ± 0.113 | 0.31 ± 0.109 |
| γ-GT, μkat/L | 0.35 ± 0.333 | 0.52 ± 0.425 | 0.20 ± 0.087 |
| Leukocytes, 109/L | 6.34 ± 1.41 | 6.51 ± 1.74 | 6.19 ± 1.09 |
| Erythrocytes, 1012/L | 4.59 ± 0.382 | 4.80 ± 0.408 | 4.41 ± 0.253 |
| Hemoglobin, g/dL | 14.4 ± 1.05 | 15.2 ± 0.91 | 13.7 ± 0.57 |
| Hematocrit, % | 42.6 ± 3.31 | 45.0 ± 2.71 | 40.4 ± 2.05 |
| Platelets, 109/L | 258 ± 66.7 | 236 ± 49.1 | 278 ± 75.3 |
| Lymphocytes, 109/L | 2.05 ± 0.437 | 2.06 ± 0.501 | 2.04 ± 0.389 |
| Monocytes, 109/L | 0.54 ± 0.196 | 0.58 ± 0.215 | 0.49 ± 0.174 |
| Basophils, 109/L | 0.072 ± 0.026 | 0.068 ± 0.0236 | 0.075 ± 0.0283 |
| Polynuclear neutrophils, 109/L | 3.47 ± 1.26 | 3.54 ± 1.52 | 3.41 ± 1.03 |
| Mean corpuscular volume, fL | 92.8 ± 3.94 | 94.2 ± 4.36 | 91.7 ± 3.22 |
| MCHC, g/dL | 33.8 ± 0.65 | 33.7 ± 0.71 | 33.9 ± 0.60 |
| Erythrocyte distribution width, % | 13.7 ± 1.23 | 13.7 ± 0.77 | 13.6 ± 1.55 |
| Mean platelet volume, fL | 9.48 ± 1.04 | 9.56 ± 1.03 | 9.41 ± 1.08 |
1
Values are means ± SD. MCHC, mean corpuscular hemoglobin concentration; SGOT, serum glutamic-oxaloacetic transaminase; SGPT, serum glutamic pyruvic transaminase; γ-GT, gamma-glutamyltransferase.